Rheumatic fever prophylaxis: Gisborne experience

Area of Science:

• Cardiology
• Infectious Diseases
• Public Health

Background:

• Rheumatic fever poses a significant risk of recurrent episodes, leading to severe cardiac complications.
• Secondary prophylaxis is crucial in preventing recurrent attacks of rheumatic fever.

Purpose of the Study:

• To evaluate the effectiveness of different penicillin prophylaxis strategies for secondary prevention of rheumatic fever.
• To compare recurrence rates between oral and parenteral benzathine penicillin administration.

Main Methods:

• Retrospective analysis of 300 rheumatic fever admissions at Cook Hospital (1958-1983).
• Comparison of recurrence rates in patients receiving oral penicillin (1958-1973) versus parenteral benzathine penicillin (1974-1983).
• Statistical analysis to determine the significance of recurrence risk reduction with parenteral prophylaxis.

Main Results:

• Recurrence rates decreased from 35% with oral penicillin to 18% with parenteral benzathine penicillin.
• Parenteral prophylaxis significantly reduced the risk of recurrence (p = 0.0009).
• Six years after the first attack, recurrence risk was 35% with oral prophylaxis versus 2% with parenteral prophylaxis.

Conclusions:

• Parenteral benzathine penicillin is a highly effective method for secondary prophylaxis of rheumatic fever.
• Coordinated hospital and community health services are essential for an effective prophylaxis program.
• Transitioning to parenteral penicillin significantly lowers long-term recurrence risk.